Biospecifics Technologies Corp (NASDAQ:BSTC)

42.76
Delayed Data
As of Apr 20
 -1.07 / -2.44%
Today’s Change
38.05
Today|||52-Week Range
58.79
-1.32%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$298.9M

Company Description

BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its product includes XIAFLEX, is an injectable collagenase enzyme, which is used for the treatment of Dupuytren's contracture in adults with a palpable cord in the palm. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Contact Information

Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook New York 11563
P:(516) 593-7000
Investor Relations:

Employees

Shareholders

Other institutional36.69%
Individual stakeholders36.39%
Mutual fund holders19.52%

Top Executives

Thomas L. WegmanPresident, CEO & Principal Financial Officer